A Novel Imidazopyridine Derivative Exerts Anticancer Activity by Inducing Mitochondrial Pathway-Mediated Apoptosis
Compound 9i inhibits HeLa cell survival in a time- and concentration-dependent manner. (a) Scheme of compound 9i. (b) Hela cell viability after different concentrations of compound 9i treated for 48 hours. (c) HeLa cell survival rate after indicated concentrations of compound 9i treatment for 24, 48, and 72 hours, respectively. Cell viability was measured using the MTT assay. Survival rate equals to compound 9i-treated cells compared to vehicle control cells; DMSO was used as a vehicle control. Data is represented as (). Significance was tested by Student’s -test (,).
Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.